FDA Inspection
Repligen CorporationRepligen Corporation – FDA Inspection, Feb 8, 2024
Record Details
This FDA Inspection record concerns Repligen Corporation, with an inspection on February 8, 2024, issued by the Dallas District Office, covering medical devices & rad health.
- Company
- Repligen Corporation
- Inspection Date
- February 8, 2024
- Product Type
- Medical Devices & Rad Health
- Office
- Dallas District Office
View Company Profile
ID · b376683b-7c2d-4895-9916-e29c25df34ba
Inspection Facts
- Inspection number
- 1230139
- FDA center
- Medical Devices & Rad Health
- Outcome
- Form 483 issued
Other FDA inspections of Repligen Corporation
4| Date | Classification | Office | Project area |
|---|---|---|---|
| January 25, 2018 | Not classified | Dallas District Office | |
| November 4, 2013 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| August 7, 2013 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| March 26, 2009 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
Other documents for Repligen Corporation
- FDA Inspection 1041140 - 2018-01-25
- FDA Inspection 853838 - 2013-11-04
- FDA Inspection 843335 - 2013-08-07
- FDA Inspection 572949 - 2009-03-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.